Gene-edited immune cells could help wipe out deadly tumors.
The first clinical trials are slated to begin in the U.S. and Europe while others are stalled.
A potential life-changer for 37 million people.
The gene-editing technology’s cancer treatment safety test could start later this year
As we discussed in previous entries of our Blog, clinical trial results are being routinely withheld from doctors, researchers and patient…